The U.S. Food and Drug Administration is reportedly reshuffling its top drug and biologics regulators in a major internal shakeup, according to a newly surfaced memo.

The move caps off a turbulent week at the agency following the recent departure of FDA Commissioner Marty Makary just days earlier, fueling further questions over the agency’s direction and leadership.